Analyst Update Buy - Stocks of the Day

Stocks of the Day

Sign In / Sign Up

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Home
Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Register Free
Sign in

Search mobile

Topic :

Analyst Update Buy

NYSE, PRO, Tickers

#Analyst Update Buy #Events Upcoming

PROS to Host Investor Fireside Chat at Outperform 2021 Virtual User Conference

November 11, 2021
09:00

EST

HOUSTON–(BUSINESS WIRE)–PROS Holdings, Inc. (NYSE: PRO), a provider of SaaS solutions optimizing shopping and selling experiences, today announced that it will host a virtual investor fireside chat at Outperform 2021, its annual user conference. The investor fireside chat will be webcast live on Wednesday, November 17, 2021, at 2:30

No Comments

FB, NASDAQ, Tickers

#Analyst Update Buy

Metaverse Here We Come: Why This Matterport Analyst Is Bullish As Facebook Rebrands

October 29, 2021
15:09

EST

Meta is the new name for social media platform company Facebook Inc (NASDAQ: FB). The name change comes as the company bets on the growth of the metaverse and augmented and virtual reality becoming more mainstream in the future. An analyst is calling out a name to watch as

No Comments

FB, NASDAQ, Tickers

#Analyst Update Buy

Metaverse Here We Come: Why This Matterport Analyst Is Bullish As Facebook Rebrands

October 29, 2021
15:09

EST

Meta is the new name for social media platform company Facebook Inc (NASDAQ: FB). The name change comes as the company bets on the growth of the metaverse and augmented and virtual reality becoming more mainstream in the future. An analyst is calling out a name to watch as

No Comments

ASLE, NASDAQ, Tickers

#Analyst Update Buy

Prescience Point Capital Management Publishes Analysis of AerSale Corporation with Strong Buy Rating and a Near-Term Price Target of $47

October 27, 2021
08:27

EST

BATON ROUGE, La., Oct. 27, 2021 /PRNewswire/ – Prescience Point Capital Management, a research-focused, catalyst-driven investment firm that seeks to earn superior risk-adjusted returns uncorrelated to the broader market, announced today that it has published a detailed analysis of AerSale Corporation (Nasdaq: ASLE) (“AerSale” or “the Company”) with a Strong

No Comments

ASLE, NASDAQ, Tickers

#Analyst Update Buy

Prescience Point Capital Management Publishes Analysis of AerSale Corporation with Strong Buy Rating and a Near-Term Price Target of $47

October 27, 2021
08:27

EST

BATON ROUGE, La., Oct. 27, 2021 /PRNewswire/ – Prescience Point Capital Management, a research-focused, catalyst-driven investment firm that seeks to earn superior risk-adjusted returns uncorrelated to the broader market, announced today that it has published a detailed analysis of AerSale Corporation (Nasdaq: ASLE) (“AerSale” or “the Company”) with a Strong

No Comments

NASDAQ, PLUG, Tickers

#Analyst Update Buy

Why This Plug Power Analyst Is Turning Bullish Ahead Of Investor Day

October 13, 2021
12:00

EST

Plug Power Inc. (NASDAQ: PLUG) received a bullish recommendation from Morgan Stanley ahead of the hydrogen fuel-cell energy company’s Thursday investor event, Plug Symposium 2021. The Plug Power Analyst: Stephen Byrd upgraded Plug Power shares from Equal-weight to Overweight and increased the price target from $35 to $40. The

No Comments

NASDAQ, PLUG, Tickers

#Analyst Update Buy

Why This Plug Power Analyst Is Turning Bullish Ahead Of Investor Day

October 13, 2021
12:00

EST

Plug Power Inc. (NASDAQ: PLUG) received a bullish recommendation from Morgan Stanley ahead of the hydrogen fuel-cell energy company’s Thursday investor event, Plug Symposium 2021. The Plug Power Analyst: Stephen Byrd upgraded Plug Power shares from Equal-weight to Overweight and increased the price target from $35 to $40. The

No Comments

KNTE, NASDAQ, Tickers

#Analyst Update Buy #Clinical Achievement Positive Results #Medical Condition Cancer

Repare Therapeutics (RPTX) Gets a Buy Rating from Bloom Burton

October 11, 2021
08:16

EST

Share this on WhatsApp Bloom Burton analyst Prasath Pandurangan maintained a Buy rating on Repare Therapeutics (RPTX – Research Report) today and set a price target of $49.00. The company’s shares closed last Friday at $20.46, close to its 52-week low of $19.82. According to TipRanks.com, Pandurangan is a

No Comments

NASDAQ, OLMA, Tickers

#Analyst Update Buy #Clinical Achievement Positive Results #Medical Condition Cancer

Repare Therapeutics (RPTX) Gets a Buy Rating from Bloom Burton

October 11, 2021
08:16

EST

Share this on WhatsApp Bloom Burton analyst Prasath Pandurangan maintained a Buy rating on Repare Therapeutics (RPTX – Research Report) today and set a price target of $49.00. The company’s shares closed last Friday at $20.46, close to its 52-week low of $19.82. According to TipRanks.com, Pandurangan is a

No Comments

NASDAQ, Tickers, TYRA

#Analyst Update Buy #Clinical Achievement Positive Results #Medical Condition Cancer

Repare Therapeutics (RPTX) Gets a Buy Rating from Bloom Burton

October 11, 2021
08:16

EST

Share this on WhatsApp Bloom Burton analyst Prasath Pandurangan maintained a Buy rating on Repare Therapeutics (RPTX – Research Report) today and set a price target of $49.00. The company’s shares closed last Friday at $20.46, close to its 52-week low of $19.82. According to TipRanks.com, Pandurangan is a

No Comments

< Page1 Page2 Page3 … Page46 >

Trending News

Helbiz Provides Transparency on Filed Proxy Statement

01/27/2023

CNEY Announces Proposed Underwritten Public Offering of Securities

01/27/2023

CNEY Reports Its Audited Financial Results for Fiscal Year 2022

01/27/2023

Hannon Armstrong Announces 2022 Dividend Income Tax Treatment

01/27/2023

DecisionPoint Systems Launches MobileConductor Express

01/27/2023

Most read news

STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace)

01/23/2023

Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress

01/23/2023

Sona Nanotech to Acquire Cancer Therapy Developer Siva Therapeutics

01/26/2023

© 2022 stocksoftheday.

Stocks of the Day does not provide investment advice. All rights reserved.

Tools

Predictions
Stock Screener
News Archive
News Feed
News Tags
Tickers
Trending Tickers
News Sentiments
Holidays & Trading Hours

Learn

FAQ
Guides
Infographics
Affiliate Program FAQ

Account

Sign In
Register
Email Preferences
Membership Option

Company

About
Contact Us
Careers
Blog
Privacy Policy
Terms of Use
Sitemap

Partnerships

Affiliate Program
Partnerships

Create account

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

First Name

Last Name

Email

Password

I agree with the Terms of Use and Privacy Policy.

Already have an account?

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account